What analyst predict for PetMed Express NASDAQ:PETS ?
PetMed Express NASDAQ:PETS headquartered in Delray Beach is reporting their earnings on 05/07/2018 before the bell. Street forecast for the quarter ending March 2018 is $0.44.
According to stock market daily analyst this is Lower then same time previous year. PetMed Express reported EPS for the same quarter last year was $0.37.
Overview of PetMed Express NASDAQ:PETS
PetMed Express is an online pharmacy that sells drugs for pets including prescription and non prescription medicine and nutritional supplements.
It can only fill prescriptions written by veterinarians, and competes with veterinarians who derive some of their income from selling pet drugs.This competition, the company’s refusal to disclose to veterinarians where it obtains its drugs and how it handles them, and the company’s business practices have created distrust in the veterinary community from early on in the company’s history.
PetMed Express is licensed or authorized to conduct business in all 50 states in the United States and has received Vet-VIPPS accreditation by the National Association of Boards of Pharmacy (NABP).
|% Change from 52 Week Low|
|% Change from 52 Week High|